Annual Total Liabilities
$375.02 M
-$29.81 M-7.36%
December 31, 2023
Summary
- As of February 12, 2025, DVAX annual total liabilities is $375.02 million, with the most recent change of -$29.81 million (-7.36%) on December 31, 2023.
- During the last 3 years, DVAX annual total liabilities has risen by +$80.44 million (+27.31%).
- DVAX annual total liabilities is now -54.09% below its all-time high of $816.87 million, reached on December 31, 2021.
Performance
DVAX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$380.56 M
+$7.09 M+1.90%
September 30, 2024
Summary
- As of February 12, 2025, DVAX quarterly total liabilities is $380.56 million, with the most recent change of +$7.09 million (+1.90%) on September 30, 2024.
- Over the past year, DVAX quarterly total liabilities has increased by +$12.55 million (+3.41%).
- DVAX quarterly total liabilities is now -55.34% below its all-time high of $852.13 million, reached on September 30, 2021.
Performance
DVAX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
DVAX Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -7.4% | +3.4% |
3 y3 years | +27.3% | -55.3% |
5 y5 years | +153.7% | +45.3% |
DVAX Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -54.1% | at low | -53.4% | +5.9% |
5 y | 5-year | -54.1% | +38.5% | -55.3% | +53.8% |
alltime | all time | -54.1% | +6444.9% | -55.3% | +6541.6% |
Dynavax Technologies Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $380.56 M(+1.9%) |
Jun 2024 | - | $373.47 M(+1.5%) |
Mar 2024 | - | $368.08 M(-1.9%) |
Dec 2023 | $375.02 M(-7.4%) | $375.02 M(+1.9%) |
Sep 2023 | - | $368.02 M(+2.4%) |
Jun 2023 | - | $359.23 M(-11.6%) |
Mar 2023 | - | $406.19 M(+0.3%) |
Dec 2022 | $404.84 M(-50.4%) | $404.84 M(-18.8%) |
Sep 2022 | - | $498.76 M(-16.9%) |
Jun 2022 | - | $600.20 M(-16.8%) |
Mar 2022 | - | $721.49 M(-11.7%) |
Dec 2021 | $816.87 M(+177.3%) | $816.87 M(-4.1%) |
Sep 2021 | - | $852.13 M(+50.9%) |
Jun 2021 | - | $564.53 M(+44.6%) |
Mar 2021 | - | $390.36 M(+32.5%) |
Dec 2020 | $294.58 M(+8.8%) | $294.58 M(+3.7%) |
Sep 2020 | - | $284.11 M(+4.8%) |
Jun 2020 | - | $271.02 M(+9.5%) |
Mar 2020 | - | $247.43 M(-8.6%) |
Dec 2019 | $270.78 M(+83.2%) | $270.78 M(+3.4%) |
Sep 2019 | - | $261.86 M(+2.1%) |
Jun 2019 | - | $256.49 M(+1.2%) |
Mar 2019 | - | $253.44 M(+71.5%) |
Dec 2018 | $147.82 M(+668.4%) | $147.82 M(+6.1%) |
Sep 2018 | - | $139.38 M(+5.1%) |
Jun 2018 | - | $132.55 M(+2.4%) |
Mar 2018 | - | $129.45 M(+572.9%) |
Dec 2017 | $19.24 M(-6.1%) | $19.24 M(+43.6%) |
Sep 2017 | - | $13.39 M(+17.1%) |
Jun 2017 | - | $11.44 M(-10.2%) |
Mar 2017 | - | $12.74 M(-37.8%) |
Dec 2016 | $20.48 M(-30.7%) | $20.48 M(-34.0%) |
Sep 2016 | - | $31.03 M(+7.6%) |
Jun 2016 | - | $28.84 M(+14.4%) |
Mar 2016 | - | $25.21 M(-14.7%) |
Dec 2015 | $29.55 M(-21.8%) | $29.55 M(+6.6%) |
Sep 2015 | - | $27.72 M(-20.7%) |
Jun 2015 | - | $34.97 M(-5.7%) |
Mar 2015 | - | $37.10 M(-1.9%) |
Dec 2014 | $37.81 M(+106.3%) | $37.81 M(+49.3%) |
Sep 2014 | - | $25.32 M(+11.1%) |
Jun 2014 | - | $22.80 M(+15.5%) |
Mar 2014 | - | $19.73 M(+7.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2013 | $18.33 M(-26.5%) | $18.33 M(-5.0%) |
Sep 2013 | - | $19.30 M(-0.3%) |
Jun 2013 | - | $19.35 M(-10.8%) |
Mar 2013 | - | $21.69 M(-13.0%) |
Dec 2012 | $24.93 M(-27.2%) | $24.93 M(-28.3%) |
Sep 2012 | - | $34.76 M(+11.5%) |
Jun 2012 | - | $31.19 M(-3.4%) |
Mar 2012 | - | $32.30 M(-5.6%) |
Dec 2011 | $34.22 M(+6.5%) | $34.22 M(+20.1%) |
Sep 2011 | - | $28.49 M(-0.4%) |
Jun 2011 | - | $28.60 M(-1.4%) |
Mar 2011 | - | $29.01 M(-9.7%) |
Dec 2010 | $32.14 M(-27.1%) | $32.14 M(-16.7%) |
Sep 2010 | - | $38.58 M(-34.5%) |
Jun 2010 | - | $58.87 M(+27.7%) |
Mar 2010 | - | $46.08 M(+4.5%) |
Dec 2009 | $44.09 M(-40.8%) | $44.09 M(-0.1%) |
Sep 2009 | - | $44.12 M(-0.9%) |
Jun 2009 | - | $44.54 M(-22.9%) |
Mar 2009 | - | $57.78 M(-22.4%) |
Dec 2008 | $74.47 M(-8.4%) | $74.47 M(+0.4%) |
Sep 2008 | - | $74.18 M(-4.7%) |
Jun 2008 | - | $77.84 M(-1.8%) |
Mar 2008 | - | $79.29 M(-2.5%) |
Dec 2007 | $81.32 M(+241.4%) | $81.32 M(+91.6%) |
Sep 2007 | - | $42.43 M(+9.7%) |
Jun 2007 | - | $38.67 M(+74.2%) |
Mar 2007 | - | $22.20 M(-6.8%) |
Dec 2006 | $23.82 M(+315.7%) | $23.82 M(+10.3%) |
Sep 2006 | - | $21.60 M(+151.4%) |
Jun 2006 | - | $8.59 M(+31.7%) |
Mar 2006 | - | $6.53 M(+13.9%) |
Dec 2005 | $5.73 M(-58.4%) | $5.73 M(-19.6%) |
Sep 2005 | - | $7.12 M(-0.9%) |
Jun 2005 | - | $7.19 M(+20.6%) |
Mar 2005 | - | $5.96 M(-56.7%) |
Dec 2004 | $13.77 M(-84.5%) | $13.77 M(+58.4%) |
Sep 2004 | - | $8.69 M(-36.3%) |
Jun 2004 | - | $13.65 M(-3.3%) |
Mar 2004 | - | $14.12 M(-84.1%) |
Dec 2003 | $88.78 M(+1.1%) | $88.78 M |
Dec 2002 | $87.85 M(+77.4%) | - |
Dec 2001 | $49.53 M(+4.1%) | - |
Dec 2000 | $47.59 M | - |
FAQ
- What is Dynavax Technologies annual total liabilities?
- What is the all time high annual total liabilities for Dynavax Technologies?
- What is Dynavax Technologies annual total liabilities year-on-year change?
- What is Dynavax Technologies quarterly total liabilities?
- What is the all time high quarterly total liabilities for Dynavax Technologies?
- What is Dynavax Technologies quarterly total liabilities year-on-year change?
What is Dynavax Technologies annual total liabilities?
The current annual total liabilities of DVAX is $375.02 M
What is the all time high annual total liabilities for Dynavax Technologies?
Dynavax Technologies all-time high annual total liabilities is $816.87 M
What is Dynavax Technologies annual total liabilities year-on-year change?
Over the past year, DVAX annual total liabilities has changed by -$29.81 M (-7.36%)
What is Dynavax Technologies quarterly total liabilities?
The current quarterly total liabilities of DVAX is $380.56 M
What is the all time high quarterly total liabilities for Dynavax Technologies?
Dynavax Technologies all-time high quarterly total liabilities is $852.13 M
What is Dynavax Technologies quarterly total liabilities year-on-year change?
Over the past year, DVAX quarterly total liabilities has changed by +$12.55 M (+3.41%)